Literature DB >> 12185164

Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease.

M-J Lee1, I Nelson, H Houlden, M G Sweeney, D Hilton-Jones, J Blake, N W Wood, M M Reilly.   

Abstract

X-linked Charcot-Marie-Tooth disease (CMTX) is a clinically heterogeneous hereditary motor and sensory neuropathy with X-linked transmission. Common clinical manifestations of CMTX, as in other forms of Charcot-Marie-Tooth disease (CMT), are distal muscle wasting and weakness, hyporeflexia, distal sensory disturbance, and foot deformities. Motor nerve conduction velocity is reduced. In male patients it is often less than 38 m/s in the median nerve (a value often used to distinguish between "demyelinating" and "axonal" forms of CMT), but in female patients conduction velocity may be faster than this or normal. Mutations in the connexin32 (gap junction protein beta 1 (GJB1)) gene are responsible for the majority of CMTX cases. This report describes six British CMTX families with six novel mutations (four missense, one nonsense, and one frame shift) of the GJB1 gene. Affected members in these six families had typical signs of CMT but in some affected members of three families there was additional central nervous system involvement or deafness in the absence of any other explanation other than CMT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185164      PMCID: PMC1738041          DOI: 10.1136/jnnp.73.3.304

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

2.  X-linked Charcot-Marie-Tooth disease and multiple sclerosis.

Authors:  Y Parman; F Ciftci; M Poyraz; A M Halefoglu; A E Oge; M Eraksoy; G Saruhan-Direskeneli; F Deymeer; E Battaloglu
Journal:  J Neurol       Date:  2007-01-30       Impact factor: 4.849

Review 3.  Gap junctions couple astrocytes and oligodendrocytes.

Authors:  Jennifer L Orthmann-Murphy; Charles K Abrams; Steven S Scherer
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

Review 4.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

Review 5.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  A novel GJB1 frameshift mutation produces a transient CNS symptom of X-linked Charcot-Marie-Tooth disease.

Authors:  Hideya Sakaguchi; Satoshi Yamashita; Akiko Miura; Tomoo Hirahara; En Kimura; Yasushi Maeda; Tadashi Terasaki; Teruyuki Hirano; Makoto Uchino
Journal:  J Neurol       Date:  2010-09-21       Impact factor: 4.849

7.  A new mutation in GJC2 associated with subclinical leukodystrophy.

Authors:  Charles K Abrams; Steven S Scherer; Rafael Flores-Obando; Mona M Freidin; Sarah Wong; Eleonora Lamantea; Laura Farina; Vidmer Scaioli; Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

8.  Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations.

Authors:  Knut Brockmann; Steffi Dreha-Kulaczewski; Peter Dechent; Carsten Bönnemann; Gunther Helms; Marten Kyllerman; Wolfgang Brück; Jens Frahm; Kathrin Huehne; Jutta Gärtner; Bernd Rautenstrauss
Journal:  J Neurol       Date:  2008-04-21       Impact factor: 4.849

9.  A zebrafish model for Waardenburg syndrome type IV reveals diverse roles for Sox10 in the otic vesicle.

Authors:  Kirsten Dutton; Leila Abbas; Joanne Spencer; Claire Brannon; Catriona Mowbray; Masataka Nikaido; Robert N Kelsh; Tanya T Whitfield
Journal:  Dis Model Mech       Date:  2008-12-22       Impact factor: 5.758

Review 10.  How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?

Authors:  Kleopas A Kleopa; Charles K Abrams; Steven S Scherer
Journal:  Brain Res       Date:  2012-07-06       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.